From the Journals
Commentary & Perspectives
Influencer Drug Promotion Raises Concerns
-
By
-
March 23, 2026
-
6 min
-
1
Influencer marketing of prescription drugs raises public health concerns.
-
2
Study covered 12 articles from a pool of 3,502 records.
-
3
Misinformation and regulatory gaps were major findings.
-
4
Personal narratives may obscure promotional intent.
-
5
Clear disclosure standards for influencer partnerships are necessary.
-
6
The review calls for improved digital health literacy among consumers.
-
7
Regulatory guidance should adapt to social media dynamics.
-
8
Diverse study designs limit conclusive findings about real-world effects.
